Literature DB >> 25264477

Wnt/β-Catenin Signaling Pathway Inhibitors: A Promising Cancer Therapy.

Ahmed F Abdel-Magid1.   

Abstract

Year:  2014        PMID： 25264477      PMCID： PMC4173633          DOI： 10.1021/ml500276a

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  4 in total

Review 1.  Identification of Wnt family inhibitors: a pituitary tumor directed whole genome approach.

Authors:  Marianne S Elston; Roderick J Clifton-Bligh
Journal:  Mol Cell Endocrinol       Date:  2010-03-06       Impact factor: 4.102

Review 2.  The Wnt signaling pathway: implications for therapy in osteosarcoma.

Authors:  Peter McQueen; Samia Ghaffar; Yi Guo; Elyssa M Rubin; Xiaolin Zi; Bang H Hoang
Journal:  Expert Rev Anticancer Ther       Date:  2011-08       Impact factor: 4.512

Review 3.  Wnt/beta-catenin signaling: a promising new target for fibrosis diseases.

Authors:  Y Guo; L Xiao; L Sun; F Liu
Journal:  Physiol Res       Date:  2012-06-06       Impact factor: 1.881

Review 4.  Importance of Wnt signaling in the tumor stroma microenvironment.

Authors:  Maria L Macheda; Steven A Stacker
Journal:  Curr Cancer Drug Targets       Date:  2008-09       Impact factor: 3.428
  4 in total
  9 in total

1.  Kindlin-2 inhibited the growth and migration of colorectal cancer cells.

Authors:  Yuanyuan Ren; Hongsong Jin; Zhidong Xue; Qianlang Xu; Songhua Wang; Guojun Zhao; Junxing Huang; He Huang
Journal:  Tumour Biol       Date:  2015-01-30

2.  Over-expression of Sox4 and β-catenin is associated with a less favorable prognosis of osteosarcoma.

Authors:  Zheng-Qi Bao; Chang-Chun Zhang; Yu-Zhou Xiao; Jian-Sheng Zhou; Yi-Sheng Tao; Da-Min Chai
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-04-13

3.  L-securinine inhibits the proliferation of A549 lung cancer cells and promotes DKK1 promoter methylation.

Authors:  Shuwen Han; Xi Yang; Yuefen Pan; Quan Qi; Junjun Shen; Huifen Fang; Zhaoning Ji
Journal:  Oncol Lett       Date:  2017-08-01       Impact factor: 2.967

Review 4.  Advances in Research on Anticancer Properties of Salidroside.

Authors:  An-Qi Sun; Xiu-Lian Ju
Journal:  Chin J Integr Med       Date:  2020-03-06       Impact factor: 1.978

5.  The identification of specific methylation patterns across different cancers.

Authors:  Chunlong Zhang; Hongyan Zhao; Jie Li; Hongbo Liu; Fang Wang; Yanjun Wei; Jianzhong Su; Dongwei Zhang; Tiefu Liu; Yan Zhang
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

Review 6.  Molecular targets of luteolin in cancer.

Authors:  Muobarak J Tuorkey
Journal:  Eur J Cancer Prev       Date:  2016-01       Impact factor: 2.497

7.  JMJD2C triggers the growth of multiple myeloma cells via activation of β‑catenin.

Authors:  Ming Lv; Qicai Liu
Journal:  Oncol Rep       Date:  2021-01-14       Impact factor: 3.906

8.  The landscape of DNA methylation-mediated regulation of long non-coding RNAs in breast cancer.

Authors:  Chunlong Zhang; Xinyu Wang; Xuecang Li; Ning Zhao; Yihan Wang; Xiaole Han; Ce Ci; Jian Zhang; Meng Li; Yan Zhang
Journal:  Oncotarget       Date:  2017-05-08

9.  ICG-001 suppresses growth of gastric cancer cells and reduces chemoresistance of cancer stem cell-like population.

Authors:  Yi Liu; Hui Chen; Peiming Zheng; Yingxia Zheng; Qin Luo; Guohua Xie; Yanhui Ma; Lisong Shen
Journal:  J Exp Clin Cancer Res       Date:  2017-09-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.